Normal view MARC view ISBD view

Targeted drug delivery to the brain via intranasal nanoemulsion: Available proof of concept and existing challenges. [electronic resource]

By:

Chatterjee, Bappaditya

Contributor(s):

Producer: 20191206Description: 258-268 p. digitalISSN:

1873-3476

Subject(s):

Online resources:

Available from publisher's website

In: International journal of pharmaceutics vol. 565

Tags from this library: No tags from this library for this title. Log in to add tags.

Average rating: 0.0 (0 votes)

No physical items for this record

Publication Type: Journal Article; Review

There are no comments on this title.

to post a comment.

Back to results

401 Evaluation of the GeneXpert assay in the detection of Factor V Leiden and prothrombin 20210 in stored, previously classified samples.
by Gessoni, G
402 [Frequently associated genotypes to thrombophilia].
by Hernández-Cuervo, Helena
403 Simultaneous measurement of ATP release and LTA does not potentiate platelet aggregation to epinephrine.
by Lordkipanidzé, Marie
404 Determinants of elevated factor VIII in patients screened for thrombophilia.
by Gajek, Aldona
405 The determination of enzyme-cofactor dissociation constants by kinetic methods: a correction.
by Jesty, J
406 [Congenital combined deficiency of factor V and factor VIII in two siblings].
by Murai, Y
407 Priapism revealing ARG 506 to GLN factor V mutation.
by de Prost, D
408 IgA nephropathy associated with mild type-coagulation factor V deficiency in father and son.
by Imai, H
409 Relative risk of pulmonary embolism and deep vein thrombosis in association with the factor V Leiden mutation in a United Kingdom population.
by Baglin, T P
410 The prothrombin gene 3'-untranslated region mutation is frequently associated with factor V Leiden in thrombophilic patients and shows ethnic-specific variation in allele frequency.
by Howard, T E
411 Factor V Leiden--a novel etiology of the long-standing thrombosis theory for recurrent pregnancy loss.
by Younis, J S
412 [Content of the factor V in hypertension].
by URBANIUK, K G
413 [On some new esters of chloramphenicol. V. Spectrophotometric determination of some esters of chloramphenicol].
by LANZA, P
414 The thromboplastin generation test; some practical modifications and study of the rôle of factors V and VII on the formation of plasma thromboplastin.
by VERSTRAETE, M
415 The stability of Ac-globulin and of prothrombin in citrated human plasma.
by FAHEY, J L
416 Factor V inhibitor in celiac disease.
by Taillan, B
417 Proaccelerin and prothrombin assays for detection of hepatocellular carcinoma.
by Lefrère, J J
418 A rapid technique for the preparation of factor V deficient plasma.
by Bloom, J W
419 Phospholipid-protein interactions in the formation of prothrombin activator.
by Cole, E R
420 Influence of misleading publications on general practitioners and purchasers.
by Hattersley, A T